| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | INNATE IMMUNOTHERAPEUTIC AUD | Jan 26, 2017 | |
| Buy | Innate Immunotherapeutic | Jan 26, 2017 | |
| Buy | Innate Immunotherapeutics Lt | Jan 23, 2015 |
This page tracks congressional stock trading activity in IINN. Disclosed Capitol has indexed 3 disclosed congressional trades involving IINN. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of January 2017 — Disclosed Capitol has tracked 3 disclosed congressional trades in IINN — 2 buys with no recorded sells — led by K. Michael Conaway (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jan 26, 2017 | K. Michael Conaway | R | Buy | $1,001 - $15,000 |
| Jan 26, 2017 | John Culberson | R | Purchase | $1,001 - $15,000 |
| Jan 23, 2015 | Tom Price | R | Purchase | $1,001 - $15,000 |
Across the 3 disclosed congressional trades in IINN, members of Congress have reported 2 buys and 0 sells.
As of May 2026, corporate insiders at IINN have filed 4 SEC Form 4 transactions in IINN over the past 12 months — including 3 sells worth $99K.
| Date | Insider | Action | Value |
|---|---|---|---|
| 2026-05-28 | Tehila Yafit — Chief Financial Officer | Sale | $38K |
| 2026-05-28 | Tehila Yafit — Chief Financial Officer | Option Exercise | — |
| 2026-05-27 | Tehila Yafit — Chief Financial Officer | Option Exercise | $2K |
| 2026-05-27 | Tehila Yafit — Chief Financial Officer | Sale | $28K |
| 2026-05-27 | Tehila Yafit — Chief Financial Officer | Sale | $33K |
Insider transactions are parsed from SEC Form 4 filings and shown alongside the congressional trades above. Institutional 13F positions are tracked separately on the institutional holdings page.